Fougera Pharmaceuticals, LLC FDA Inspection Record

FEI 2410271 · Inspections, Form 483s, warning letters and import refusals

Fougera Pharmaceuticals, LLC is an FDA-registered facility (FEI 2410271) located in Hicksville, NY, US. Registered operations: LABEL; MANUFACTURE; PACK. RegDataLab tracks 13 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Mar 26, 2026: Voluntary Action Indicated (VAI)
Inspections on record
13 (13 VAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Form 483 and inspection documents
1 in FDA's reading room
Recalls as the recalling firm
1, latest Jun 7, 2012

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 13 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 26, 2026Voluntary Action Indicated (VAI)Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Nov 17, 2023Voluntary Action Indicated (VAI)Investigations of discrepancies, failures (21 CFR 211.192)
Aug 10, 2022Voluntary Action Indicated (VAI)Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Absence of Written Procedures (21 CFR 211.100(a))
Aug 8, 2019Voluntary Action Indicated (VAI)Written procedures not established/followed (21 CFR 211.67(b))
May 29, 2018Voluntary Action Indicated (VAI)Procedures for non-sterile drug products (21 CFR 211.113(a))
Nov 10, 2016Voluntary Action Indicated (VAI)Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Failing drug products not rejected (21 CFR 211.165(f))
Dec 23, 2014Voluntary Action Indicated (VAI)No citations listed
Dec 20, 2013Voluntary Action Indicated (VAI)Labeling and packaging improperly approved/released (21 CFR 211.122(b))
Nov 16, 2012Voluntary Action Indicated (VAI)Packaging line inspection documentation (21 CFR 211.130(e))
Feb 1, 2012Voluntary Action Indicated (VAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jun 7, 2012Class IIID-1426-2012Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA &…
Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the…

Form 483s and inspection documents

  • 483 on FDA.gov
    FDA listing date Mar 26, 2026, which is not always the inspection or issue date. Published by FDA Oct 22, 2026.

FDA record score

13 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

13 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIMar 26, 20266 x 16
Inspection classified VAINov 17, 20236 x 0.63.6
Inspection classified VAIAug 10, 20226 x 0.63.6
Inspection classified VAIAug 8, 2019Only the 3 most recent VAI inspections add points0
Inspection classified VAIMay 29, 2018Only the 3 most recent VAI inspections add points0
Inspection classified VAINov 10, 201610 years or older, so it adds no points0
Inspection classified VAIDec 23, 201410 years or older, so it adds no points0
Inspection classified VAIDec 20, 201310 years or older, so it adds no points0
Inspection classified VAINov 16, 201210 years or older, so it adds no points0
Inspection classified VAIFeb 1, 201210 years or older, so it adds no points0
Inspection classified VAIFeb 9, 201110 years or older, so it adds no points0
Inspection classified VAIJan 12, 201010 years or older, so it adds no points0
Inspection classified VAIFeb 6, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Fougera Pharmaceuticals, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Fougera Pharmaceuticals, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Fougera Pharmaceuticals, LLC.
Location
Hicksville, NY (US)
Registration Expires
Dec 31, 2027
Operations
LABEL; MANUFACTURE; PACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.